Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:04
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
53rd ERA-EDTA Congress
21-24 May 2016 Vienna
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
53rd ERA-EDTA Congress
Topic -
Chronic Kidney Disease. Bone disease.
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
ERK1/2 SIGNALING IS A MODULATOR OF BM-MSC OSTEOGENIC DIFFERENTIATION IN HIGH-TURNOVER RENAL OSTEODYSTROPHY
Jianqing Jiang
1
5/10/2016 7:26:00 AM
CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY
Juergen Floege
1
5/9/2016 11:16:00 PM
SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY
Juergen Floege
1
5/9/2016 11:12:00 PM
VASCULAR CALCIFICATION OF THE PUDENDAL ARTERY IS A SENTINEL FOR ELEVATED PULSE WAVE VELOCITY
Paul Jeronimo
1
5/9/2016 10:24:00 PM
VASCULARCALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4, 5 AND 5D:RECAVAS STUDY.
JOSE LUIS GORRIZ TERUEL
1
5/9/2016 10:06:00 PM
MINERAL METABOLISM OUTCOMES OF A TREATMENT PROTOCOL FOR CONTROLLING SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A PROSPECTIVE COHORT STUDY.
Eva Gavela Martínez
1
5/9/2016 10:03:00 PM
EFFECTS OF A REGIMEN BASED ON RESTRICTED CALCIUM INTAKE FROM PHOSPHATE BINDERS, LOW DOSE VITAMIN D SUPPLEMENTATION , AND PARICALCITOL, ON SURVIVAL, HOSPITALIZATION AND RENAL PROGRESSION. A PROSPECTIVE COHORT STUDY IN NON-DIALYSIS CKD PATIENTS.
Eva Gavela Martínez
1
5/9/2016 9:56:00 PM
aKLOTHO AND FIBROBLAST GROWTH FACTOR 23 ARE NOT ASSOCIATED WITH THE DECREASE OF TUBULAR PHOSPHATE REABSORBTION IN EARLY CKD: EXPERIMENTAL AND CLINICAL STUDY
Evdokia Bogdanova
1
5/9/2016 7:35:00 PM
THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY
Adriana Dusso
1
5/9/2016 7:00:00 PM
FGF23, IRON STATUS AND VITAMIN D METABOLISM IN CHRONIC KIDNEY DISEASE
Isabelle Piec
1
5/9/2016 5:53:00 PM
CHRONIC KIDNEY DISEASE DISTURBS CARDIAC CALCIUM HANDLING DUE TO HIGH FGF23 LEVELS
Melissa Verkaik
1
5/9/2016 11:54:00 AM
TREATMENT OF PERSISTENT HYPERCALCEMIA IN KIDNEY TRANSPLANT RECIPIENTS WITH CINACALCET
Ayssegul ORUC
1
5/9/2016 11:51:00 AM
ENDOTHELIAL DYSFUNCTION IN EXPERIMENTAL CHRONIC KIDNEY DISEASE IS CAUSED BY FGF23
Melissa Verkaik
1
5/9/2016 11:51:00 AM
VITAMIN D DEFICIENCY AND ELEVATED PTH BUT NOT FGF-23 PREDICT ALL-CAUSE MORTALITY IN PEOPLE WITH CKD STAGE 3 IN PRIMARY CARE
Adam Shardlow
1
5/8/2016 10:23:00 PM
ARE MEDICINAL PRODUCTS A RELEVANT SOURCE OF HIDDEN EXTRA-PHOSPHATE LOAD IN CKD PATIENTS ?
Adamasco Cupisti
1
5/8/2016 5:02:00 PM
LOW MAGNESIUM LEVELS ARE CLOSELY RELATED WITH FGF-23 LEVELS AND ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS
Zeynep Bal
1
5/6/2016 9:26:00 PM
CHOLECALCIFEROL SUPPLEMENTATION IN HEMODIALYSIS: NO RISKS AND POSSIBLE NUTRITIONAL BENEFIT
MAKROUHI SONIKIAN
1
5/6/2016 8:14:00 PM
IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS.
Yuriy Milovanov
1
5/6/2016 5:55:00 PM
VITAMIN D RECEPTOR ACTIVATION INCREASES SERUM SCLEROSTIN IN CKD PATIENTS: A RANDOMIZED CLINICAL TRIAL
Claudia Torino
1
5/6/2016 11:47:00 AM
SOLUBLE KLOTHO AND FIBROBLAST GROWTH FACTOR 23 LEVELS IN DIABETIC NEPHROPATHY: RELATIONSHIP WITH ARTERIAL STIFFNESS
Ayca Inci
1
5/6/2016 11:47:00 AM
ELECTIVE PARATHYROID SURGERY IN DIALYSIS PATIENTS WITH CHRONIC RENAL FAILURE AND MORTALITY
Deborah Sylvester
1
5/5/2016 10:26:00 PM
CALCITRIOL ALTERS THE PATHOLOGICAL PHENOTYPE ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN AN EXPERIMENTAL MODEL OF CHRONIC KIDNEY DISEASE
Mandy Turner
1
5/5/2016 8:22:00 PM
BONE DISEASE CHARACTERIZATION IN A GROUP OF PREDIALYSIS PATIENTS
Ricardo Neto
1
5/5/2016 1:01:00 AM
DOES CHOLECALCIFEROL CORRECT SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?
Cristina Capusa
1
5/4/2016 8:21:00 PM
INFLAMMATION BUT NOT DERANGED MINERAL METABOLISM MAY EXPLAIN THE PROGRESSION OF CORONARY ARTERY CALCIFICATION IN CKD PATIENTS NOT ON DIALYSIS
Luigi Russo
1
5/3/2016 3:17:00 PM
PHOSPHATE CONTAINING PRESCRIPTION MEDICATIONS CONTRIBUTE TO THE DAILY PHOSPHATE INTAKE IN A THIRD OF HEMODIALYSIS PATIENTS
Rachel Holden
1
5/2/2016 8:31:00 PM
ADDITION OF SEVELAMER AND MORTALITY: THE WORLDWIDE DOPPS STUDY
Hirotaka Komaba
1
4/30/2016 2:52:00 AM
THE RESULTS OF NONINVASIVE BONE MINERAL DENSITY STUDIES IN CHILDREN AND ADULTS WITH END-STAGE RENAL FAILURE ON HEMODIALYSIS
Abay Shepetov
1
4/17/2016 12:53:00 PM
IRON CITRATE REDUCES HIGH PHOSPHATE-INDUCED VASCULAR CALCIFICATION BY INHIBITING APOPTOSIS
mario cozzolino
1
4/16/2016 9:17:00 AM
Most viewed poster for this congress
Poster:
547
Visits:
1241
Title:
COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors:
Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre:
Fresenius Medical Care Portugal
Poster most viewed in this topic
Poster:
365
Visits:
28
Title:
SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY
Authors:
Jrgen Floege ,
Centre:
RWTH University Hospital Aachen, Department of Nephrology and Clinical Immunology, Aachen, Germany
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: